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Abstract 
Dendritic cell-based immunotherapy of malignant diseases relies on two critical parameters: 
antigen transport from the periphery to draining lymph nodes and efficient priming of primary 
and stimulation of secondary immune responses. Prostaglandin E2 (PGE2) signaling has been 
shown to be pivotal for DC migration towards lymph node-derived chemokines in vitro and in 
vivo. Here, we demonstrate that PGE2 induced the expression of the co-stimulatory molecules 
OX40L, CD70, and 4-1BBL on human DCs. Short triggering by PGE2 early during DC 
maturation was sufficient to induce the co-stimulatory molecules. The expression of the co-
stimulatory molecules was independent of the maturation stimulus but strictly dependent on 
PGE2 on both monocyte-derived (Mo)DCs and peripheral blood myeloid (PB)DCs. PGE2-
matured MoDCs showed enhanced co-stimulatory capacities resulting in augmented antigen-
specific CD4
+ and CD8
+ T cell proliferation in primary and recall T cell responses. Blocking 
OX40:OX40L signaling impaired the enhanced T cell proliferation induced by PGE2-matured 
MoDCs. Moreover, MoDCs matured in the presence of PGE2 induced the expression of 
OX40, OX40L, and CD70 on T cells facilitating T cell-T cell interaction that warrant long 
lasting co-stimulation. This newly identified parameter will help to further optimize DC-based 
immunotherapy. 
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Introduction 
Dendritic cells (DCs) are key players in the defense against pathogens due to their unique 
capacity to induce primary and secondary T cell responses. By presenting specific antigens on 
MHC and by expressing co-stimulatory molecules, DCs provide both essential signals for 
optimal T cell activation, prevention of tolerance and development of T cell immunity. The 
most important co-stimulatory receptor for early proliferation of naïve T cells is CD28 which 
interacts with CD80 or CD86 on DCs 
1. However, CD28-CD80/86 co-stimulatory interactions 
cannot fully account for an efficient long-lasting T cell response or the generation of memory 
T cells 
2. T cell proliferation and survival at later phases and the development of memory T 
cells depends on additional co-stimulatory molecules belonging to the TNF:TNFR 
superfamily and include OX40L:OX40, 4-1BBL:4-1BB and CD70:CD27 
3.  
OX40 is induced on activated T cells and provides an essential signal for optimal CD4
+ T cell 
function 
4-7 as well as for the generation of memory T cells 
8-10 by prolonging the survival of 
effector T cells 
9. Signaling through OX40 is controlled in vivo by the availability of its ligand 
OX40L. The expression of OX40L is tightly regulated and can be induced on APCs such as 
DCs 
11,12 and B cells 
13 and microglia 
14. The lack of OX40L on APCs results in a marked 
reduction of cytokine production and proliferation of T helper cells 
5,7. Murine DCs 
transfected with mRNA encoding OX40L induce enhanced anti-tumor activity in vivo, while 
transfection of OX40L mRNA in human MoDCs improves the induction of antigen-specific 
CTLs in vitro 
15. 
CD27 is expressed on naïve CD4
+ and CD8
+ T cells 
16 and on primed B cells 
17 and triggering 
of CD27 by CD70 supports T cell survival. Consequently, constant activation of CD27 by 
persistent transgenic expression of CD70 on mouse B cells leads to excessive T cell 
proliferation 
18,19). CD70 expression is transiently induced on T, B cells and DCs after antigen 
receptor engagement or TLR stimulation 
20-22. CD70 expression on activated DCs is important 
for expansion and survival of primed CD8
+ T cells in mice 
23-25. In addition to its expression 
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on DCs, OX40L and CD70 can be induced on T cells, providing a mechanism by which co-
stimulatory survival signals are delivered by T cell-T cell contacts responsible for keeping T 
cells alive after APCs and antigens are no longer available to generate memory cells 
26. 
Due to their natural features, DCs are currently used as cellular vaccines against tumors and 
infectious diseases 
27. As DCs in peripheral blood are very rare, the development of a protocol 
to differentiate blood monocytes into immature DCs in vitro 
28, a process that also occurs in 
vivo 
29,30, boosted the feasibility of DC-based immunotherapies. DC maturation can be 
induced by addition of sCD40L, polyI:C, LPS or a cocktail of pro-inflammatory cytokines 
comprising TNF-α, interleukin (IL)-1ß, IL-6 and prostaglandin E2 (PGE2) 
28,31,32. The 
presence of the arachidonic acid metabolite PGE2 during DC maturation is fundamental for 
the acquisition of a migratory DC phenotype both in vitro  and  in vivo 
32-34, and hence 
essential for the transport of antigen from the periphery to draining lymph nodes and the 
induction of an antigen-specific immune response. Langerhans cells deficient in the PGE2 
receptor EP4 display a significantly reduced T cell stimulatory capacity 
33. Moreover, 
stimulation of human monocyte-derived DCs (MoDC) with PGE2 enhances their ability to 
induce allogeneic as well as antigen-specific T cell proliferation 
32,35,36. The mechanism by 
which PGE2 induces enhanced T cell stimulatory capacities in mature DCs has not been 
identified yet. 
In the present study, we demonstrate that the expression of the co-stimulatory molecules 
OX40L and CD70 on mature MoDCs depends on PGE2 stimulation resulting in a 
significantly enhanced capacity to induce antigen-specific CD4
+ and CD8
+ T cell 
proliferation. 
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Materials and Methods 
Generation of monocyte-derived dendritic cells (MoDCs) 
Human monocytes were positively selected from whole blood of healthy donors as previously 
described 
32,34. Briefly, peripheral blood mononuclear cells (PBMC) were enriched by density 
gradient centrifugation on Ficoll Paque Plus (Amersham Biosciences, Uppsala Sweden) and 
CD14
+ monocytes were isolated using anti-CD14 conjugated microbeads (Miltenyi Biotec, 
Bergisch-Gladbach, Germany). Monocytes were cultured at 1x10
6 cells/ml in serum-free 
AIM-V medium (Gibco, Paisley, UK) supplemented with 50 ng/ml GM-CSF (Leukomax
®, 
Novartis, Basel, Switzerland) and IL-4 (recombinant protein from PromoCell, Heidelberg, 
Germany, or supernatant of an IL-4 producing J558 cell line; both revealed identical results). 
Where indicated MoDCs were generated in AIM-V containing 5% human AB serum (Lonza, 
Basel, Switzerland). After 5-6 days, immature DCs were harvested and matured for 2 days by 
addition of 0.5 μg/ml soluble trimeric CD40L (sCD40L; PromoCell), 20 µg/ml poly I:C 
(Sigma, St Louis, MO), 10 μg/ml LPS (Salmonella abortus equi; Sigma) or a combination of 
20 ng/ml TNF-α, 10 ng/ml IL-1β and 20 ng/ml IL-6 (all PromoCell). Maturation occurred in 
the absence or presence of 1 μg/ml PGE2 (Minprostin
® E2, Pharmacia, Uppsala, Sweden), a 
concentration found in inflammation and used for clinical applications. For antigen loading 10 
μg/ml KLH (Sigma) or TT (Berna Biotech AG, Berne, Switzerland) were added during DC 
maturation.  
 
Peripheral blood DCs (PBDCs) 
Myeloid CD1c
+ DCs were isolated from PBMCs using the CD1c (BDCA-1) dendritic cell 
isolation kit (Miltenyi Biotec) according to the manufacturer’s instructions. PBDC were 
analyzed by flow cytometry directly after isolation (ex vivo), or cultured at 1x10
6 in AIM-V 
medium supplemented with 50 ng/ml GM-CSF and 50 ng/ml IL-4 (PromoCell). After two 
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days of maturation with 0.5 μg/ml soluble trimeric CD40L in the absence or presence of 1 
μg/ml PGE2, cells were analyzed by flow cytometry.  
 
Co-cultures and T cell proliferation assay 
Purified CD3
+ T cells (pan T cell isolation kit; Miltenyi Biotec) or PBMCs were labeled with 
CFSE (Molecular Probes, Eugene, OR) according to the manufacturer’s protocol. 
Subsequently 1x10
5 autologous MoDCs were cultured together with 1x10
6 PBMCs or 
purified T cells in 1 ml AIM-V medium. Where indicated graded amounts of a goat anti-
human OX40L neutralizing antibody (R&D Systems, Minneapolis MN) or control goat IgG 
(R&D Systems) were added. After 6 or 12 days of co-culture, T cell proliferation was 
assessed by CSFE dilution assays using flow cytometry. 
 
Flow cytometry 
For cell surface staining of co-stimulatory molecules, MoDCs were incubated for 45 min at 
4°C in PBS containing 1% FCS and 0.02% sodium azide with anti-CD83-PE, anti-CD80-PE, 
anti-CD86-PE, anti-OX40L-PE (clone Ik-1), anti-CD70-PE (clone Ki-24), or IgG-PE isotype 
control antibodies (all from BD Biosciences, Erembodegen, Belgium) and analyzed by flow 
cytometry (LSRII, BD Biosciences). T cell proliferation was assessed by measuring CFSE 
dilution of cells stained with anti-CD3-APC/Cy7, anti-CD4-PE/Cy7, anti-CD8-APC (BD 
Biosciences). Dead cells were excluded by Sytox Blue (Molecular Probes) staining. Surface 
expression of co-stimulatory molecules of non-labeled T cells was measured using anti-CD3-
APC/Cy7, CD4-PE/Cy7, CD8-PacificBlue in combination with either anti-OX40L-PE and 
anti-OX40-FITC or anti-CD70-PE (BD Biosciences). 
 
 
 
For personal use only. on October 31, 2014.  by guest    www.bloodjournal.org From - 7 - 
Quantitative real-time RT-PCR 
Total RNA from MoDCs matured with sCD40L in the absence or presence of PGE2 was 
isolated using the RNeasy mini kit (Qiagen, Hilden, Germany) and transcribed into cDNA 
using random hexamer primers and the Taqman
® reverse transcription kit (Applied 
Biosystems, Rotkreuz, Switzerland) according to the manufacture’s instructions. 
Amplification of TNFSF4, TNFSF7 and TNFSF9 mRNA was performed using the 
QuantiTect SYBR Green PCR Master Mix (Qiagen) on a Taqman 7700 (Applied Biosystems) 
with an initial denaturation step at 95°C for 15 min followed by 40 cycles of 15 sec at 94°C, 
30 sec at 60°C and 30 sec at 72°C. Forward and reverse primers were used at a concentration 
of 200 nM with the following sequences: TNFSF4: 5’-CACCTACATCTGCCTGCACTTCT, 
5’-GTTGTTCTGCACCTTCATGATTTC; TNFSF7: 5’-CCTCGTGGTGTGCATCCA, 5’-
ATGCCATCACGATGGATACGTA; TNFSF9: 5’-GAGCTTTCGCCCGACGAT, 5’-
GCAGCTCTAGTTGAAAGAAGACATAGTAGA. Expression of mRNA was normalized to 
ß-2 microglobulin (ß2M) and ubiquitin C (UBC) using SYBR Green PCR Master Mix 
(Applied Biosystems) containing 200 nM forward and reverse primer (ß2M: 5’-
GCTATCCAGCGTACTCCAAAGATTC and 5’-CAACTTCAATGTCGGATGGATGA; 
UBC: 5’-ATTTGGGTCGCGGTTCTTG and 5’-TGCCTTGACATTCTCGATGGT). Relative 
mRNA expression was calculated by the ΔΔCt-method.  
 
Statistical evaluation 
Differences between groups were assessed by the student’s paired t test. 
For personal use only. on October 31, 2014.  by guest    www.bloodjournal.org From - 8 - 
Results 
PGE2 potentiates the capacity of human MoDCs to induce T cell proliferation 
It is well established that PGE2 is the crucial factor during MoDC maturation to generate DCs 
with a migratory phenotype under serum-free conditions 
32,34. Moreover, MoDCs matured in 
the presence of PGE2 show an enhanced capacity to stimulate allogenic T cell proliferation 
32,35. To determine whether this effect also applies to antigen-specific T cell stimulation, we 
generated MoDCs matured with soluble trimeric CD40L (sCD40L) in the absence or presence 
of PGE2 under serum-free conditions and co-cultured them with autologous CFSE-labeled 
PBMCs. MoDCs from tetanus toxoid (TT) vaccinated donors were pulsed either with TT to 
induce secondary (memory) T cell responses or keyhole limpet hemocyanin (KLH) to 
promote primary (naïve) T cell responses. Immature antigen-pulsed MoDCs elicited only 
weak T cell proliferation after six days of co-culture (Fig 1A, B), as expected due to the lack 
of CD83 expression and weaker expression of CD80 and CD86 compared to mature MoDCs 
(Fig 1C). MoDC maturation by CD40 ligation did not strongly improve T cell proliferative 
responses (Fig 1A, B), despite high surface expression of CD83, CD80 and CD86 (Fig 1C). 
By contrast, MoDCs matured in the presence of PGE2 promoted strong antigen-specific 
primary and secondary T cell proliferation (Fig 1A, B), although expression levels of CD83, 
CD80 and CD86 were not further increased by the addition of PGE2 (Fig 1C). Moreover, the 
augmented stimulatory capacity of PGE2-matured MoDCs affected both CD4
+ and CD8
+ T 
cells (Fig 1A, B). Latter must occur by cross-presentation as both antigens, if delivered 
exogenously to DCs, are known to be presented to CTLs by this pathway 
36,37. 
 
PGE2 induces the expression of co-stimulatory molecules of the TNF superfamily on 
mature MoDCs and PBDCs 
To investigate on the mechanism responsible for the enhanced T cell activating properties of 
PGE2-matured MoDCs, we analyzed the gene expression profiles of MoDCs matured with 
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sCD40L in the absence or presence of PGE2 derived from 5 individual donors by Affymetrix 
GeneChip arrays. We found non-classical co-stimulatory molecules of the TNF superfamily, 
namely TNFSF4 (OX40L, CD134), TNFSF7 (CD70, CD27L), and TNFSF9 (4-1BBL, 
CD137L) to be up-regulated in MoDCs matured in the presence of PGE2, whereas the 
expression levels of CD80 and CD86 remained unchanged (data not shown). We corroborated 
these findings by quantitative real-time PCR revealing a 10- to 30-fold higher mRNA 
expression of OX40L, CD70 and 4-1BBL in PGE2-matured MoDCs (Fig 2A). Next, we 
assessed cell surface expression of the co-stimulatory molecules on MoDCs by flow 
cytometry. Immature MoDCs did not express OX40L and CD70, and stimulation with PGE2 
alone had no effect (Fig 2B, C). Both co-stimulatory molecules were also absent in DCs after 
24 h or 48 h of maturation with sCD40L. However, MoDC matured by CD40 ligation in the 
presence of PGE2 markedly expressed OX40L and CD70 (Fig 2B, C) on the cell surface on 
day two. Since we cultivated MoDCs under serum-free conditions, a prerequisite for 
immunotherapy, we investigated whether the observed necessity for PGE2 to induce OX40L 
and CD70 expression on mature MoDCs was due to serum deprivation in our culture system. 
Therefore, we generated MoDCs in medium containing human AB serum and induced 
maturation using sCD40L with or without addition of PGE2. Even in the presence of serum 
PGE2 was crucial for OX40L and CD70 expression on mature MoDCs as MoDCs matured in 
the absence of PGE2 did not express those co-stimulatory molecules (Fig 2D). We could not 
detect surface expression of 4-1BBL on MoDCs which may be due to the poor quality of 
antibodies specific for human 4-1BBL. 
Next, we investigated the expression of co-stimulatory molecules on human peripheral blood 
myeloid (PB)DCs. Ex vivo PBDCs are CD83
-, CD80
-, CD86
low (data not shown and 
34) and 
do not express OX40L and CD70 (Fig 3A). Stimulation of ex vivo PBDCs with sCD40L for 
two days induced surface expression of CD83, CD80, as well as CD86, but not OX40L and 
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CD70. As for MoDCs, PBDCs expressed OX40L and CD70 exclusively if PGE2 was added to 
the maturation stimulus (Fig 3A). 
 
Expression of OX40L and CD70 on mature MoDCs is PGE2-dependent 
To test whether up-regulation of OX40L and CD70 on DCs generally depends on PGE2, we 
matured MoDCs by TLR4 or TLR3 stimulation, or by adding a cytokine cocktail consisting of 
TNF-α, IL-1ß, and IL-6. Interestingly, MoDC maturation by sCD40L, LPS, poly I:C, or a 
cocktail of cytokines in the absence of PGE2 was never accompanied by the expression of 
OX40L (Fig 3B), whereas MoDCs matured in the presence of PGE2 always expressed 
OX40L, independently of the maturation stimulus used (Fig 3B). Similarly, CD70 expression 
on MoDCs was only detectable if PGE2 was added during maturation (Fig 3C). In some 
donors, maturation via TLR3 signaling alone led to low expression of CD70, which was 
strongly enhanced in the presence of PGE2 (Fig 3C). In vivo, peripheral DCs are exposed to 
PGE2 that is produced very early during inflammation by monocytes, macrophages, fibroblast 
and keratinocytes 
38,39 only for a short period of time as they rapidly leave the inflammatory 
milieu. Therefore, we determined whether a short stimulation with PGE2 during the first hours 
of maturation was sufficient to up-regulate OX40L and CD70 expression on mature MoDCs. 
As depicted in Fig 3D, both OX40L and CD70 were expressed on MoDCs after a maturation 
time of 48 h if PGE2 was added exclusively for the initial 3 hours of maturation. A prolonged 
presence of PGE2 further increased surface expression of both co-stimulatory molecules in 
some donors, but was dispensable in others. 
 
PGE2-induced augmentation of T cell stimulatory capacities of MoDCs is inhibited by 
OX40L blockage 
To determine the impact of PGE2-induced OX40L expression on human MoDCs, we co-
cultured antigen-pulsed MoDCs matured in the absence or presence of PGE2 with autologous 
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PBMCs while blocking the OX40L:OX40 interaction using a neutralizing goat anti-human 
OX40L antibody. First, we used TT-pulsed MoDCs from TT vaccinated donors to investigate 
the role of OX40:OX40L signaling on a recall, secondary immune response. After six days of 
co-culture, neutralizing OX40L antibody inhibited the PGE2-dependent enhanced 
proliferation of both CD4
+ and CD8
+ T cell populations in a concentration-dependent manner, 
whereas an irrelevant control goat IgG had no effect (Fig 4A, B). The effect of OX40L 
blockage was even more pronounced on day 12 of co-culture (Fig 4C, D), which can be 
explained by the anti-apoptotic signal provided by OX40 leading to survival of proliferating T 
cells 
9. Noteworthy, the inhibition by OX40L neutralization was not complete, suggesting that 
CD70, and maybe 4-1BBL contribute to the enhanced T cell proliferation induced by PGE2-
matured MoDCs. As there are currently no neutralizing antibodies for human CD70 and 4-
1BBL commercially available, we were not able to address their contribution. Next, we tested 
whether the enhanced primary T cell response induced by KLH-pulsed, PGE2-matured 
MoDCs was also mediated by OX40:OX40L. Indeed, neutralizing OX40L antibody 
significantly impaired the enhanced expansion of CD4
+ and CD8
+ T cells induced by PGE2-
matured MoDCs at day six and 12 (Fig 5). 
To rule out a possible role of non-T cells in our co-culture system, we purified CD3
+ T cells 
and co-cultured them separately with autologous TT- and KLH-pulsed MoDCs matured in the 
presence or absence of PGE2. Similar to T cells in total PBMCs, cultivation of purified CD3
+ 
T cells with MoDCs resulted in enhanced proliferation of CD4
+ and CD8
+ T cells when 
antigen-bearing MoDCs were matured in the presence of PGE2 (Fig 6). Moreover, the PGE2-
induced augmentation of T cell stimulatory capacities of MoDCs was reduced by blocking the 
OX40L:OX40 interaction (Fig 6).  
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PGE2-matured MoDCs induce expression of OX40L, OX40 and CD70 in T cells 
Co-stimulatory molecules are also involved in contacts between T cells. Expression of 
OX40L on activated CD4
+ T cells has been reported to contribute to an enhanced T cell 
survival by triggering OX40 on adjacent T cells 
26. To test whether T cells interacting with 
(PGE2-) matured MoDCs up-regulate co-stimulatory molecules and thus deliver an 
amplification signal, we measured the expression of OX40L and OX40 on CD4
+ T cells after 
two and six days of co-culture of PBMCs with autologous antigen-pulsed MoDCs matured 
with sCD40L in the absence or presence of PGE2. The percentage of OX40L expressing T 
helper cells increased in co-cultures with PGE2-matured MoDCs (Fig 7A, B). This holds true 
for both primary KLH-mediated, and secondary TT-mediated immune responses and was 
observed at day two and even more profoundly at day six of co-culture. Moreover, OX40 is 
induced in CD4
+ T cells after activation rendering them susceptible to OX40L-mediated 
survival signals 
2, and CD4
+ T cells from co-cultures with TT-pulsed MoDCs matured in the 
presence of PGE2 expressed significantly more OX40 than those co-cultured with MoDCs 
matured in the absence of PGE2 (Fig 7C). In addition, significantly more T cells expressed 
OX40 when responding to the primary antigen KLH presented by PGE2-matured MoDCs (Fig 
7D). Since the expression of CD70 can be induced on T cells after TCR engagement 
20,21, we 
determined the surface expression level of CD70 on CD4
+ and CD8
+ T cells after six days of 
stimulation by TT-pulsed (Fig 7E) or KLH-pulsed (Fig 7F) MoDCs matured in the absence or 
presence of PGE2. Significantly more CD4
+ and CD8
+ T cells expressed CD70 on the surface 
in co-cultures with PGE2-matured MoDCs compared to MoDCs matured in the absence of the 
arachidonic acid metabolite. The expression of OX40L and CD70 on CD4
+ T cells was not 
restricted to proliferating T cells, but was also observed on a population of non-proliferating T 
cells; and a population of proliferating cells lacked expression of the two co-stimulatory 
molecules (data not shown). 
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In summary, we provide clear evidence that the inflammatory mediator PGE2 is critical during 
DC maturation permitting efficient proliferation of antigen-specific CD4
+ and CD8
+ T cells. 
We demonstrate for the first time that PGE2 induces the up-regulation of the co-stimulatory 
molecules OX40L, CD70 and 4-1BBL on human DCs correlating with an enhanced capacity 
to elicit primary and secondary T cell responses. Blocking OX40:OX40L signaling impaired 
the enhanced T cell proliferation induced by PGE2-matured MoDCs. Moreover, MoDCs 
matured in the presence of PGE2 induce the expression of OX40, OX40L, and CD70 on T 
cells which provide prolonged survival signals. Together with the fact that PGE2 facilitates 
DC migration permitting the transport of antigens to draining lymph nodes, PGE2 also enables 
DCs to deliver an efficient co-stimulatory signal for naïve and memory CD4
+ and CD8
+ T cell 
responses. 
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Discussion 
The exceptional ability of dendritic cells to induce antigen-specific immune responses has 
brought them into the focus of cell-based immunotherapy of malignant diseases. As the 
quantity of sufficient numbers of primary human DCs is a limiting factor, MoDCs are used as 
source of DCs in most clinical studies. Large numbers of monocytes can be isolated from 
peripheral blood of patients and differentiated in vitro under serum-free conditions into 
immature MoDCs, which are fully competent to take up and process antigens. The pulsing 
with tumor-antigens and induction of maturation results in antigen-presenting DCs, which can 
potently activate tumor antigen-specific immune responses. We and others have shown 
previously, that supplementation of the maturation stimulus with PGE2 at concentrations 
found at inflammatory sites is critical to generate MoDCs with a migratory phenotype 
32,34,40. 
Particularly, the presence of PGE2 in the initial phase of maturation is essential to promote 
DC migration towards lymph node-derived chemokines 
34. Interestingly, PGE2 also affects T 
cell stimulatory properties of MoDCs. Allogenic T cell proliferation was enhanced in mixed 
lymphocyte reactions if MoDCs were matured in the presence of PGE2 
32,35. In the present 
study we provide evidence, that PGE2-matured MoDCs have an enhanced potential to induce 
antigen-specific T cell proliferation by up-regulating the expression of the co-stimulatory 
molecules OX40L, CD70, and 4-1BBL. The expression of OX40L on mature DCs was shown 
to prolong survival of OX40-bearing CD4
+ T cells at the late phase of a primary immune 
response contributing to the development of a larger pool of memory T cells 
4,9. 
Consequently, mice lacking OX40L expression on mature DCs are unable to mount a specific 
cellular anti-tumor response 
41. Conversely, transfection of murine DCs with mRNA encoding 
OX40L augmented the induction of an anti-tumor response 
15. On human MoDCs, a rather 
weak induction of OX40L expression has been described after TNF-α and CD40L stimulation 
11. In the present study, we identify PGE2 as a key factor for the expression of OX40L and 
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CD70 on the surface of mature MoDCs (Fig 2) and PBDCs (Fig 3A). For four different 
maturation stimuli, we observed OX40L and CD70 expression exclusively if DCs were 
matured in the presence of PGE2 (Fig 3B, C). Noteworthy, addition of the TLR7/8 ligand 
resiquimod (R-848) to polyI:C and PGE2 for MoDC maturation resulted in migratory DCs 
that produced high amounts of IL-12p70 (data not shown and 
42). However, addition of 
resiquimod does not induce full maturation of MoDCs (
43 and own observation). 
Consequently, we did not detect expression of OX40L and CD70 on MoDCs matured by 
polyI:C and resiquimod even in the presence of PGE2 (data not shown). For all other 
maturation stimuli tested, PGE2 induced OX40L and CD70 on DCs. 
The enhanced proliferation of antigen-specific T cells induced by MoDCs matured in the 
presence of PGE2 was partially reversed by anti-body-mediated blockage of OX40:OX40L 
interactions (Fig 4-6). Blocking OX40L:OX40 signaling not only inhibited CD4
+ T cell 
proliferation, but also strongly hampered the expansion of CD8
+ T cells (Fig 4-6) even though 
OX40 is described to primarily affect CD4
+ T cell proliferation. However, we detected OX40 
expression on 2-15% of CD8
+ T cells after 6 days of co-culture with PGE2-matured MoDCs, 
while OX40 expression was mostly absent if MoDCs were matured in the absence of PGE2 
(data not shown). The inhibitory effect of OX40L-blockage on CD8
+ T cell proliferation may 
be indirect due to impaired CD4
+ T cell help occurring through multiple mechanisms 
including cytokine production and supply of co-stimulatory signals. A role of OX40 on co-
stimulation of CD8
+ T cells is described, although the signal is weaker than that delivered by 
4-1BB 
44. In fact, we also found a profound up-regulation of 4-1BBL mRNA on MoDCs 
matured in the presence of PGE2 (Fig 2A), which may contribute to the enhanced CTL 
response. Unfortunately, we could not investigate on the role of human 4-1BBL:4-1BB 
signaling in our co-culture system due to the lack of specific antibodies. Expression of CD70 
on activated DCs contributes to the expansion of CD8
+ T cells leading to the generation of 
memory CD8
+ T cells even in the absence of T cell help 
45. In fact, binding of CD70 to CD27 
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promoted survival of activated T cells, rather than augmenting cell cycle progression 
46 and 
blocking CD70 completely abrogated mouse CD8
+ T cell proliferation 
23. Recently, it has 
been reported that CD70 must be expressed by DCs for efficient priming of CD8
+ T cells to 
eliminate pathogens in vivo 
24. The observation that antigen-induced expansion of CD8
+ T 
cells is dependent on CD70 expression by DCs, highlights the importance of our finding that 
CD70 expression in human MoDCs fully depended on the presence of PGE2 during 
maturation (Fig 3C). Additionally, we found that PGE2-matured MoDCs induced CD70 
expression on proliferating and non-proliferating CD4
+ and CD8
+ T cells (Fig 7E, F). T cell - 
T cell interaction mediated by CD70 and CD27 is a relatively early event after priming 
47 and 
plays a critical role not only in T cell activation but also in T cell-dependent modulation of B 
cell functions (reviewed in 
16). Similarly to CD70, OX40L expression was induced on CD4
+ T 
cells upon stimulation by MoDCs matured in the presence of PGE2 (Fig 7A, B). OX40L 
expressed on T cells provides a potent co-stimulatory signal leading to augmented CD4
+ T 
cell proliferation and sustained CD4
+ T cell longevity 
26,48. OX40:OX40L interaction between 
T cells was suggested to occur in T cell zones of lymph nodes or spleen and to sustain T cell 
survival after OX40L expression on APCs had diminished 
48. Therefore, the induction of 
OX40L and CD70 on T cells by PGE2-matured MoDCs ensures the maintenance of survival 
signals through T cell-T cell contacts resulting in sustained and enhanced antigen-specific 
immune responses. 
 
Triggering co-stimulatory molecules on APCs and T cells also modulates the profile of 
cytokine production 
16 and hence strongly influences the outcome of a T cell-mediated 
immune response. CD4
+ T cells producing high amounts of IFN-γ are referred to as Th1 cells 
and play a major role in the defense against intracellular pathogens and tumors, whereas CD4
+ 
T cells producing IL-4, IL-5 and IL-13 are termed Th2 cells and mediate immunity against 
helminth infection 
49. Interestingly, a recent report points to CD70 as a decision marker for an 
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IL-12 independent IFN-γ production/Th1 differentiation by a DEC205
+ DC subset in vivo 
50. 
The role of OX40 in T cell differentiation is more complex. On the one hand, OX40 
engagement was shown to enhance IL-4 production of T cells resulting in Th2 effector cell 
differentiation 
48,51,52. On the other hand, in experimental allergic encephalomyelitis and an 
inflammatory Bowel disease model, OX40:OX40L interactions promoted the generation of 
Th1 responses 
14,53. Moreover, OX40L triggering on DCs enhanced its production of IL-12 
11 
favoring Th1 differentiation, and CD4
+ T cells co-cultured with MoDCs matured in the 
presence of PGE2 produced the Th1 cytokines IFN-γ and TNF-α, but only little IL-4 
36. Due 
to these controversial observations, it may be that OX40L:OX40 interactions rather support 
the survival of activated T cells, which then differentiate dependent on the balance of existing 
cytokines, than serving as decision maker for Th1/Th2 differentiation. 
 
An anti-tumor immune response is usually weaker than a response to pathogens due to the 
lack of danger signals. Moreover, the tumor environment can be immunosuppressive resulting 
in antigen-specific tolerization of T cells. Stimulation of OX40 can restore antigen-specific 
proliferation and cytokine production by anergic CD4
+ T cells, suggesting that OX40 signals 
can reverse established tolerance. Along this line, OX40 signaling has been shown to enhance 
anti-tumor immune responses resulting in tumor rejection in a variety of tumor models 
54-56. 
Breaking tumor-specific tolerance is of pivotal importance for the success of immunotherapy. 
The induction of OX40L on MoDCs by PGE2 could hence be a crucial parameter for DC-
based immunotherapy. However, overcoming tolerance is not the only challenge 
immunotherapy is facing. The presence and induction of regulatory T cells (Treg) in tumors 
poses another problem. Interestingly, OX40 stimulation on T cells not only increases the 
frequencies of antigen-specific effector and memory T cells, but renders CD25
-CD4
+ T cells 
insusceptible to Treg-mediated suppression 
57. Moreover, co-stimulation by OX40 inhibited 
TGF-β-driven Foxp3 expression in CD25
-CD4
+ T cells and prevented the induction of new 
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Tregs from effector T cells and suppressed the functions of natural Foxp3
+ Tregs 
58,59. Thus, 
up-regulation of OX40L on MoDCs by PGE2 may fulfill major functions relevant for DC-
based immunotherapies: enhancing survival of effector T cells, promoting the generation of 
memory T cells, breaking established tolerance, and suppressing natural Tregs.  
 
Besides their role in the initiation of an adaptive immune response, DCs also play a role in the 
innate immune system. A recent study demonstrated that the anti-tumor activity of NKT cells 
depended on the expression of OX40L on DCs 
41, thus further emphasizing the importance of 
PGE2-mediated OX40L up-regulation on MoDCs. 
 
In conclusion, we demonstrate that human MoDCs greatly enhance their capacity to activate 
naïve and memory, as well as CD4
+ and CD8
+ T cells if matured in the presence of PGE2 by 
up-regulating co-stimulatory molecules of the TNF superfamily. Surface expression of 
OX40L and CD70 on PBDCs and MoDCs strictly depended on PGE2 stimulation. Expression 
of OX40L and CD70 on migratory DCs have the potential to improve the efficacy of 
immunotherapy by promoting protective effector and memory T cell responses, by hampering 
antigen-specific tolerance, and by attenuating the suppressor activity of Tregs. Beside its 
established role in facilitating DC migration, PGE2-dependent expression of OX40L and 
CD70 on mature human MoDCs as described herein represents a new parameter that will help 
to further optimize DC-based immunotherapy. 
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Figure Legends 
Figure 1. PGE2 enhances T cell stimulatory capacities of human MoDCs. Human CSFE-
labeled PBMCs were stimulated with tetanus toxoid (TT) (A) or keyhole limpet hemocyanin 
(KLH) (B) pulsed autologous immature (iDC) and MoDCs matured with trimeric soluble 
CD40L (mDC) in the absence or presence of PGE2. On day 6 of the co-culture, cells were 
harvested, stained for CD3, CD4, CD8 and Sytox-Blue to identify live T cells and analyzed 
by flow cytometry. CSFE fluorescence of live CD3
+CD4
+ and CD3
+CD8
+ T cells from a 
representative experiment out of at least five is shown. Percentages of proliferating, CSFE 
low, T cells are indicated. (C) Immature (iDC) or matured MoDCs (mDC) were analyzed for 
the expression of co-stimulatory molecules by flow cytometry. MoDCs were matured with 
sCD40L in the absence or presence of PGE2. Grey thin lines represent isotype controls while 
black bold lines represent specific staining for CD83, CD80 or CD86 as indicated. 
 
Figure 2. PGE2-dependent expression of co-stimulatory molecules of the TNF 
superfamily on MoDCs. (A) Quantitative real-time RT-PCR analysis of TNFSF4 (OX40L), 
TNFSF7 (CD70) and TNFSF9 (4-1BBL) mRNA expression in MoDCs matured in the 
absence or presence of PGE2. Up-regulation of specific mRNA expression levels are depicted 
as fold increase by PGE2. Mean values and SEM derived from 7 individual donors are shown. 
Cell surface expression of OX40L (B, black bold lines) and CD70 (C, black bold lines) on 
immature MoDCs (iDC) or sCD40L-matured DCs in the absence or presence of PGE2 after 
24 h or 48 h of culture was analyzed by flow cytometry. MoDCs were generated either in 
serum-free AIM-V medium (A-C) or AIM-V medium containing 5% human AB serum (D). 
Grey thin lines represent isotype control stainings. A representative out of three (D) or at least 
five (B, C) independent experiments with different donors is shown. 
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Figure 3. Expression of OX40L and CD70 on ex vivo PBDCs and MoDCs strictly 
depends on PGE2 stimulation. (A) Myeloid DCs were isolated from peripheral blood of 
healthy donors and cell surface expression of OX40L and CD70 (black bold lines) was 
measured by flow cytometry on ex vivo DCs, or PBDCs cultured for 48 hours in medium 
alone (no stimulus), or matured with sCD40L in presence or absence of PGE2. (B-C) MoDCs 
were matured for 48 h with either sCD40L, LPS, poly I:C or a cytokine cocktail consisting of 
TNF-α, IL-1ß and IL-6, in the absence or presence of PGE2 and analyzed for surface 
expression of OX40L (B, black bold lines) and CD70 (C, black bold lines) by flow cytometry. 
(D) MoDCs were matured with sCD40L while PGE2 was present for the first 3 h or 15 h, or 
for the full period of maturation. Cell surface expression of OX40L and CD70 (black bold 
lines) was assessed by flow cytometry after 48 h of maturation. Isotype control stainings are 
presented as grey thin lines. A representative out of four independent experiments with 
different donors is shown. 
 
Figure 4. Blocking OX40L partially reversed the PGE2-induced enhanced capacity of 
MoDCs to stimulate memory T cell proliferation. MoDCs were matured with sCD40L in 
the absence (white bars) or presence (back bars) of PGE2, pulsed with tetanus toxoid (TT) and 
co-cultured with autologous CFSE-labeled PBMCs for six (A, B) or 12 days (C, D). Graded 
concentrations of a goat anti-human OX40L neutralizing antibody (squares) or control goat 
IgG (circles) were added to co-cultures with PGE2-matured MoDCs and T cell proliferation 
was analyzed by CFSE-dilution of live (SytoxBlue negative) cells. Percentages of 
proliferating, CSFE
lowCD3
+CD4
+ (A, C) or CSFE
lowCD3
+CD8
+ (B, D) T cells are presented. 
Mean values and SEM of at least four independent experiments with different donors are 
shown. * p<0.05, ** p<0.01, *** p<0.001. 
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Figure 5. The enhanced primary T cell response induced by PGE2-matured MoDCs can 
be inhibited by OX40L-blockage. MoDCs were pulsed with KLH and matured with 
sCD40L in the absence (white bars) or presence of PGE2 (black bars) for 48 h. Freshly 
isolated autologous PBMCs were labeled with CFSE and co-cultured with MoDCs at a 
PBMC to MoDC ratio of 10:1. Where indicated 5 μg/ml of a neutralizing goat anti-human 
OX40L antibody or a control goat IgG was added. CD4
+ (A, C) and CD8
+ (B, D) T cell 
proliferation on day six (A, B) or 12 (C, D) of the co-culture was analyzed by flow cytometry 
by CFSE-dilution of live (SytoxBlue negative) cells. Mean values and SEM of seven (A, B) 
or four (C, D) independent experiments with different donors are shown. * p<0.05, ** p<0.01. 
 
Figure 6. Enhanced T cell response induced by PGE2-matured MoDCs in co-cultures 
with purified CD3
+ T cells is inhibited by OX40L-blockage. MoDCs were matured with 
sCD40L in the presence (black bars) or absence (white bars) of PGE2 and pulsed with either 
TT (A, B) or KLH (C, D) for 48 h. Freshly isolated purified CD3
+ T cells were labeled with 
CFSE and co-cultured with autologous MoDCs at a T cell to MoDC ratio of 10:1. Where 
indicated, 5 μg/ml of a neutralizing goat anti-human OX40L antibody or a control goat IgG 
was added. CD4
+ ( A,  C) and CD8
+ ( B,  D) T cell proliferation was determined by flow 
cytometry on day six of the co-culture by CFSE-dilution of live (SytoxBlue negative) cells. 
Mean values and SEM of three independent experiments with different donors are shown. 
 
Figure 7. Enhanced expression of OX40L, OX40 and CD70 on T cells stimulated with 
PGE2-matured MoDCs. MoDCs were matured with sCD40L in the absence or presence of 
PGE2, pulsed with TT (A, C, E) or KLH (B, D, F) and co-cultured with autologous PBMCs. 
On day two and six of the co-culture, surface expression of OX40L (A, B), OX40 (C, D) and 
CD70 (E, F) was analyzed on CD3
+CD4
+ or CD3
+CD8
+ T cells by flow cytometry. (A-D) 
one representative experiment on day six is shown as dot plots, while diagrams display mean 
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values and SEM for at least five independent experiments with different donors. (E, F) Mean 
values and SEM of at least four independent experiments at day six are presented. * p<0.05, 
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